Inactive

RFQ AMD01-New Due Date and Update POP date US Food Drug & Administration (FDA) Center for Drug Evaluation and Research (CDER) Office of Pharmaceutical Quality (OPQ) Office of Quality Surveillance (OQS... RFQ AMD01-New Due Date and Update POP date US Food Drug & Administration (FDA) Center for Drug Evaluation and Research (CDER) Office of Pharmaceutical Quality (OPQ) Office of Quality Surveillance (OQS) is interested in new data sources and modeling tools that can be used to better understand and predict potential quality issues across its portfolio of manufacturing sites and products and for integration into the OPQ Dashboard. Historically, OQS has not used financial data in these efforts. To that end, this subscription provides access to comprehensive financial information and credit risk analysis on a variety of companies, domestic and foreign, to assist CDER in its surveillance efforts. The contractor shall provide up to five users for the access to the online subscription. The Government intends to issue a firm fixed-price purchase order as result of this solicitation. Please see the attached RFQ for complete requirement details and quotation submission instructions.